Epigenomics AG (FRA:ECX)

Epigenomics AG Revenue

Epigenomics AG had revenue of 17.00K EUR in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 30.00K, up 172.73% year-over-year. In the year 2025, Epigenomics AG had annual revenue of 24.00K.

• Revenue (ttm): 30.00K
• Revenue Growth: +172.73%
• P/S Ratio: 26.31
• Revenue / Employee: 15.00K
• Employees: 3
• Market Cap: 789.28K

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	24.00K	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	339.00K	-560.00K	-62.29%
Dec 31, 2022	899.00K	-5.30M	-85.51%
Dec 31, 2021	6.20M	5.36M	636.70%

Data Source: S&P Global Market Intelligence Last updated: Sep 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 18, 2026

Data Sources Report a data error